BSV receives approval from DCGI to conduct phase III clinical study on Ulinastatin As per approved clinical trial protocol, subjects with mild to moderate COVID-19 will be randomised in study in a 1:1 ratio with…
Medica Group of Hospitals hosts COVID-19 virtual discourse The session took viewers through clinically oriented topics ranging from defining the disease to technicalities of managing COVID…
Stempeutics partners with Global Consortium of cell therapy companies Seeking European Commission Funding to Fight Against Corona
